Anuradha K, Sailaja V V, Umabala P, Satheesh T, Lakshmi V
Department of Microbiology, Nizam's Institute of Medical Sciences, Hyderabad - 500 082, Andhra Pradesh, India.
Indian J Med Microbiol. 2007 Jul;25(3):203-8. doi: 10.4103/0255-0857.34759.
To evaluate the spectrum of activity of three beta-lactamase inhibitors such as amoxicillin/ clavulanic acid, ticarcillin/ clavulanic acid and piperacillin/ tazobactam in comparison to cephalosporins against gram negative bacilli.
Gram-negative bacilli isolated from the clinical specimens received in the laboratory were included in the study. Using the API system (bioMiotarieux) during a one-year period, a total of 1,252 Enterobacteriaceae and 385 non-fermenters were evaluated.
The percentage resistance of the Enterobacteriaceae isolates was 82.92% to amoxicillin/ clavulanic acid, 58.22% to ticarcillin/clavulanic acid and 22.44% to piperacillin/tazobactam respectively. Pseudomonas aeruginosa showed resistance of 96% to ticarcillin/ clavulanic acid and 61% to piperacillin/ tazobactam and Acinetobacter baumannii showed 49% resistance to ticarcillin/ clavulanic acid and 77% resistance to piperacillin/ tazobactam respectively. The isolates exhibited high resistance to all the generations of cephalosporins and the other groups of antibiotics except carbapenems.
Piperacillin/tazobactam was found to be the most active combination of the three against Enterobacteriaceae and Pseudomonas spp. and ticarcillin/clavulanic acid against Acinetobacter spp. and Stenotrophomonas maltophilia.
评估三种β-内酰胺酶抑制剂,即阿莫西林/克拉维酸、替卡西林/克拉维酸和哌拉西林/他唑巴坦,与头孢菌素相比,对革兰氏阴性杆菌的活性谱。
本研究纳入从实验室接收的临床标本中分离出的革兰氏阴性杆菌。在一年时间内,使用API系统(生物梅里埃公司)对总共1252株肠杆菌科细菌和385株非发酵菌进行了评估。
肠杆菌科分离株对阿莫西林/克拉维酸的耐药率分别为82.92%,对替卡西林/克拉维酸为58.22%,对哌拉西林/他唑巴坦为22.44%。铜绿假单胞菌对替卡西林/克拉维酸的耐药率为96%,对哌拉西林/他唑巴坦为61%,鲍曼不动杆菌对替卡西林/克拉维酸的耐药率为49%,对哌拉西林/他唑巴坦为77%。除碳青霉烯类抗生素外,分离株对所有代头孢菌素和其他抗生素组均表现出高耐药性。
发现哌拉西林/他唑巴坦是三种药物中对肠杆菌科和假单胞菌属最具活性的组合,替卡西林/克拉维酸对不动杆菌属和嗜麦芽窄食单胞菌最具活性。